Todd W.  Kingma net worth and biography

Todd Kingma Biography and Net Worth

VP of Perrigo
Mr. Kingma was named Executive Vice President in May 2006. He served as Vice President, General Counsel and Secretary from August 2003 to May 2006. Previously, Mr. Kingma held various positions at Pharmacia Corporation from 1991 through August 2003. His last position with Pharmacia Corporation was Vice President and Associate General Counsel, Global Specialty Operations.

What is Todd W. Kingma's net worth?

The estimated net worth of Todd W. Kingma is at least $835,731.20 as of December 20th, 2019. Mr. Kingma owns 31,184 shares of Perrigo stock worth more than $835,731 as of November 13th. This net worth estimate does not reflect any other assets that Mr. Kingma may own. Learn More about Todd W. Kingma's net worth.

How do I contact Todd W. Kingma?

The corporate mailing address for Mr. Kingma and other Perrigo executives is THE SHARP BUILDING HOGAN PLACE, DUBLIN L2, 49010. Perrigo can also be reached via phone at (531) 709-4000 and via email at [email protected]. Learn More on Todd W. Kingma's contact information.

Has Todd W. Kingma been buying or selling shares of Perrigo?

Todd W. Kingma has not been actively trading shares of Perrigo during the past quarter. Most recently, on Friday, December 17th, Todd W. Kingma bought 3,000 shares of Perrigo stock. The stock was acquired at an average cost of $37.55 per share, with a total value of $112,650.00. Learn More on Todd W. Kingma's trading history.

Who are Perrigo's active insiders?

Perrigo's insider roster includes Bradley Alford (Director), Svend Andersen (EVP), Eduardo Bezerra (CFO), Rolf Classon (Director), James Dillard, III (EVP), Thomas Farrington (EVP), Alison Ives (EVP), Ronald Janish (EVP), Murray Kessler (CEO), Todd Kingma (VP), Patrick Lockwood-Taylor (CEO), Geoffrey Parker (Director), Grainne Quinn (EVP), Theodore Samuels, II (Director), Raymond Silcock (CFO), Richard Sorota (EVP), and Robert Willis (EVP). Learn More on Perrigo's active insiders.

Are insiders buying or selling shares of Perrigo?

During the last twelve months, Perrigo insiders bought shares 8 times. They purchased a total of 42,580 shares worth more than $1,199,876.50. During the last twelve months, insiders at the sold shares 3 times. They sold a total of 50,254 shares worth more than $1,411,969.20. The most recent insider tranaction occured on September, 13th when Director Katherine C Doyle sold 8,954 shares worth more than $244,444.20. Insiders at Perrigo own 0.7% of the company. Learn More about insider trades at Perrigo.

Information on this page was last updated on 9/13/2024.

Todd W. Kingma Insider Trading History at Perrigo

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/17/2021Buy3,000$37.55$112,650.00View SEC Filing Icon  
12/20/2019Sell2,300$54.91$126,293.0031,184View SEC Filing Icon  
11/9/2018Buy3,200$63.99$204,768.0023,587View SEC Filing Icon  
12/28/2017Sell1,500$88.52$132,780.0019,565View SEC Filing Icon  
12/28/2017Sell1,500$88.52$132,780.0019,565View SEC Filing Icon  
8/25/2015Sell1,715$181.37$311,049.5510,320View SEC Filing Icon  
4/29/2015Sell1,700$190.27$323,459.00View SEC Filing Icon  
4/13/2015Sell1,300$198.44$257,972.00View SEC Filing Icon  
9/3/2014Sell2,250$149.65$336,712.50View SEC Filing Icon  
7/19/2013Sell1,250$129.37$161,712.50View SEC Filing Icon  
6/14/2013Sell1,250$118.00$147,500.00View SEC Filing Icon  
See Full Table

Todd W. Kingma Buying and Selling Activity at Perrigo

This chart shows Todd W Kingma's buying and selling at Perrigo by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Perrigo Company Overview

Perrigo logo
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Read More

Today's Range

Now: $26.80
Low: $26.33
High: $26.87

50 Day Range

MA: $26.04
Low: $24.18
High: $28.49

2 Week Range

Now: $26.80
Low: $23.89
High: $34.60

Volume

2,146,279 shs

Average Volume

1,626,817 shs

Market Capitalization

$3.66 billion

P/E Ratio

N/A

Dividend Yield

4.19%

Beta

0.48